Pulmonary embolism: Treatment of the acute episode

Italian Heart Journal

Volumn 6, Issue 10, 2005, Pages 818-823

  Casazza, Franco ^a,b   Roncon, Loris ^c   Greco, Francesco ^d  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b S Maria della Misericordia Hospital ^*  (Italy)

^c S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^d Unit of Geriatrics   (Italy)

Author keywords

Anticoagulants; Pulmonary embolism; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE DISEASE; FIBRINOLYTIC THERAPY; HUMAN; LUNG EMBOLISM; PROGNOSIS; REVIEW; TIME;

ACUTE DISEASE; FIBRINOLYTIC AGENTS; HUMANS; PROGNOSIS; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 33644697555     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960; 1: 1309-12.
2. Alpert JS, Smith R, Carson J, Ockene IS Dexter L, Dalen JE. Mortality in patients treated for pulmonary embolism. JAMA 1976; 236: 1477-80.
3. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl): 401S-428S.
4. Levine MN, Raskob GE, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl): 287S-310S.
5. Raschke RA, Gollihare B, Peirce JC. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline. Arch Intern Med 1996; 156: 1645-9.
6. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram: a randomized controlled trial. Ann Intern Med 1993; 119: 874-81.
7. Ginsberg JS. Management of venous thromboembolism. N Engl J Med 1996; 335: 1816-28.
8. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism. A meta-analysis of randomized, controlled trials. Ann Intern Med 2004; 140: 175-83.
9. Hirsh J, Raschke R. Heparin and low-molecular-weight-heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl): 188S-203S.
10. Carter CJ, Kelton JG, Hirsh J, Cerskus AL, Santos AV, Gent M. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood 1982; 59: 1239-45.
11. Kovacs MJ, Anderson D, Morrow B, Gray L, Touchie D, Wells PS. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000; 83: 209-11.
12. Buller HR, Davidson BL, Decousus H, et al, for the MATISSE Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695-702.
13. Buller HR, Davidson BL, Decousus H, et al, for the MATISSE Investigators. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004; 140: 867-73.
14. Fiessinger JN, Huisman MV, Davidson BL, et al, for the THRIVE Treatment Study Investigators. Ximelagatran vs low-molecular-weight-heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA 2005; 293: 681-9.
15. Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism. A comprehensive review of current evidence. Chest 1999; 115: 1695-707.
16. Thabut G, Thabut D, Myers RP, et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol 2002; 40: 1660-7.
17. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med 2002; 162: 2537-41.
18. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism. A meta-analysis of the randomized controlled trials. Circulation 2004; 110: 744-9.
19. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W, for the Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-50.
20. Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997; 96: 882-8.
21. Hamel E, Pacouret G, Vincentelli D, et al. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest 2001; 120: 120-5.
22. Dalen JE. Thrombolysis in submassive pulmonary embolism? No. J Thromb Haemost 2003; 1: 1130-2.
23. Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest 2002; 121: 806-14.
24. Casazza F, Bongarzoni A, Centonze F, Morpurgo M. Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism. Am J Cardiol 1997; 79: 1433-5.
25. Zonzin P, Agnelli G, Casazza F, et al. Commento alle linee guida della Task Force sull'embolia polmonare della Società Europea di Cardiologia. Ital Heart J Suppl 2001; 2: 1342-56.
26. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30: 1165-71.
27. Suarez JA, Meyerrose GE, Phisitkul S, et al. Review of catheter thrombectomy devices. Cardiology 2004; 102: 11-5.
28. Goldhaber SZ. Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. Chest 1998; 114: 1237-8.
29. Zeni PT Jr, Blank BG, Peeler DW. Use of rheolytic thrombectomy in treatment of acute massive pulmonary embolism. J Vasc Interv Radiol 2003; 14: 1511-5.
30. Reekers J, Baarslag HJ, Koolen MG, Van Delden O, van Beek EJ. Mechanical thrombectomy for early treatment of massive pulmonary embolism. Cardiovasc Intervent Radiol 2003; 26: 246-50.
31. Uflacker R. Interventional therapy for pulmonary embolism. J Vasc Interv Radiol 2001; 12: 147-64.
32. Leacche M, Unic D, Goldhaber SZ, et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005; 129: 1018-23.